-
-
-
-
-
-
-
U.S. Biotech stocks: Q1 earnings previews
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Raised to $630 at Baird
-
-
-
-
-
-
-
Regeneron (REGN) Tops Q2 EPS by 439c
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
-
-
-
-
-
-
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
-
1,204,676 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

